Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS

Azizul M. Hoque, Andreas Papapetropoulos, Richard C. Venema, John D. Catravas, Leslie C. Fuchs

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Lipopolysaccharide (LPS) causes impaired vascular contractility proposed to be mediated by induction of nitric oxide synthase (iNOS). Antisense (AS) oligonucleotide inhibits the translation of target mRNA into functional proteins. We hypothesize that in vivo pretreatment with AS oligonucleotide targeted to iNOS mRNA can prevent LPS-induced hyporeactivity to norepinephrine (NE). Three groups of conscious male Wistar rats received one of the following: saline, AS, or mismatch (MM) oligonucleotide at 0.4 mg/kg iv at 12 and 24 h before LPS (5 mg/kg iv). The fourth group received saline only. Mean arterial pressure (MAP) and heart rate (HR) were continuously recorded before and 6 h after LPS or saline administration. Aorta, lung lavage, and lung tissue were collected for determination of iNOS protein expression and NOS activity. Small mesenteric arteries (≈250 μm) were isolated, denuded of endothelium, and maintained at a constant intraluminal pressure of 40 mmHg for study in vitro. LPS produced significant tachycardia that was not altered by AS or MM oligonucleotide. AS, but not MM oligonucleotide, reduced the accumulation of cGMP, the increase in conversion of L-[3H]arginine to L-[3H]citrulline, and iNOS protein expression in tissue from LPS-treated rats. Small mesenteric arterial contraction to NE was significantly impaired in vessels from LPS-treated rats and was restored by AS, but not MM, oligonucleotide. In a rat model of septic shock, AS oligonucleotide to iNOS mRNA inhibits NOS activity and iNOS protein expression and prevents the vascular hyporeactivity to NE, which may contribute to hypotension in shock.

Original languageEnglish (US)
Pages (from-to)H1078-83
Number of pages6
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume275
Issue number3 Pt 2
StatePublished - Sep 1 1998

Fingerprint

Antisense Oligonucleotides
Nitric Oxide Synthase
Blood Vessels
Lipopolysaccharides
Hemodynamics
Oligonucleotides
Norepinephrine
Proteins
Citrulline
Messenger RNA
Mesenteric Arteries
Protein Biosynthesis
Bronchoalveolar Lavage
Septic Shock
Tachycardia
Hypotension
Endothelium
Arginine
Aorta
Wistar Rats

Keywords

  • Antisense oligonucleotide
  • Inducible nitric oxide synthase
  • Mesenteric small arteries
  • Septic shock

ASJC Scopus subject areas

  • Physiology

Cite this

Hoque, A. M., Papapetropoulos, A., Venema, R. C., Catravas, J. D., & Fuchs, L. C. (1998). Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS. American Journal of Physiology - Heart and Circulatory Physiology, 275(3 Pt 2), H1078-83.

Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS. / Hoque, Azizul M.; Papapetropoulos, Andreas; Venema, Richard C.; Catravas, John D.; Fuchs, Leslie C.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 275, No. 3 Pt 2, 01.09.1998, p. H1078-83.

Research output: Contribution to journalArticle

Hoque, AM, Papapetropoulos, A, Venema, RC, Catravas, JD & Fuchs, LC 1998, 'Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS', American Journal of Physiology - Heart and Circulatory Physiology, vol. 275, no. 3 Pt 2, pp. H1078-83.
Hoque, Azizul M. ; Papapetropoulos, Andreas ; Venema, Richard C. ; Catravas, John D. ; Fuchs, Leslie C. / Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS. In: American Journal of Physiology - Heart and Circulatory Physiology. 1998 ; Vol. 275, No. 3 Pt 2. pp. H1078-83.
@article{0d228b9a1874482fb417c0d10103b8e5,
title = "Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS",
abstract = "Lipopolysaccharide (LPS) causes impaired vascular contractility proposed to be mediated by induction of nitric oxide synthase (iNOS). Antisense (AS) oligonucleotide inhibits the translation of target mRNA into functional proteins. We hypothesize that in vivo pretreatment with AS oligonucleotide targeted to iNOS mRNA can prevent LPS-induced hyporeactivity to norepinephrine (NE). Three groups of conscious male Wistar rats received one of the following: saline, AS, or mismatch (MM) oligonucleotide at 0.4 mg/kg iv at 12 and 24 h before LPS (5 mg/kg iv). The fourth group received saline only. Mean arterial pressure (MAP) and heart rate (HR) were continuously recorded before and 6 h after LPS or saline administration. Aorta, lung lavage, and lung tissue were collected for determination of iNOS protein expression and NOS activity. Small mesenteric arteries (≈250 μm) were isolated, denuded of endothelium, and maintained at a constant intraluminal pressure of 40 mmHg for study in vitro. LPS produced significant tachycardia that was not altered by AS or MM oligonucleotide. AS, but not MM oligonucleotide, reduced the accumulation of cGMP, the increase in conversion of L-[3H]arginine to L-[3H]citrulline, and iNOS protein expression in tissue from LPS-treated rats. Small mesenteric arterial contraction to NE was significantly impaired in vessels from LPS-treated rats and was restored by AS, but not MM, oligonucleotide. In a rat model of septic shock, AS oligonucleotide to iNOS mRNA inhibits NOS activity and iNOS protein expression and prevents the vascular hyporeactivity to NE, which may contribute to hypotension in shock.",
keywords = "Antisense oligonucleotide, Inducible nitric oxide synthase, Mesenteric small arteries, Septic shock",
author = "Hoque, {Azizul M.} and Andreas Papapetropoulos and Venema, {Richard C.} and Catravas, {John D.} and Fuchs, {Leslie C.}",
year = "1998",
month = "9",
day = "1",
language = "English (US)",
volume = "275",
pages = "H1078--83",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3 Pt 2",

}

TY - JOUR

T1 - Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS

AU - Hoque, Azizul M.

AU - Papapetropoulos, Andreas

AU - Venema, Richard C.

AU - Catravas, John D.

AU - Fuchs, Leslie C.

PY - 1998/9/1

Y1 - 1998/9/1

N2 - Lipopolysaccharide (LPS) causes impaired vascular contractility proposed to be mediated by induction of nitric oxide synthase (iNOS). Antisense (AS) oligonucleotide inhibits the translation of target mRNA into functional proteins. We hypothesize that in vivo pretreatment with AS oligonucleotide targeted to iNOS mRNA can prevent LPS-induced hyporeactivity to norepinephrine (NE). Three groups of conscious male Wistar rats received one of the following: saline, AS, or mismatch (MM) oligonucleotide at 0.4 mg/kg iv at 12 and 24 h before LPS (5 mg/kg iv). The fourth group received saline only. Mean arterial pressure (MAP) and heart rate (HR) were continuously recorded before and 6 h after LPS or saline administration. Aorta, lung lavage, and lung tissue were collected for determination of iNOS protein expression and NOS activity. Small mesenteric arteries (≈250 μm) were isolated, denuded of endothelium, and maintained at a constant intraluminal pressure of 40 mmHg for study in vitro. LPS produced significant tachycardia that was not altered by AS or MM oligonucleotide. AS, but not MM oligonucleotide, reduced the accumulation of cGMP, the increase in conversion of L-[3H]arginine to L-[3H]citrulline, and iNOS protein expression in tissue from LPS-treated rats. Small mesenteric arterial contraction to NE was significantly impaired in vessels from LPS-treated rats and was restored by AS, but not MM, oligonucleotide. In a rat model of septic shock, AS oligonucleotide to iNOS mRNA inhibits NOS activity and iNOS protein expression and prevents the vascular hyporeactivity to NE, which may contribute to hypotension in shock.

AB - Lipopolysaccharide (LPS) causes impaired vascular contractility proposed to be mediated by induction of nitric oxide synthase (iNOS). Antisense (AS) oligonucleotide inhibits the translation of target mRNA into functional proteins. We hypothesize that in vivo pretreatment with AS oligonucleotide targeted to iNOS mRNA can prevent LPS-induced hyporeactivity to norepinephrine (NE). Three groups of conscious male Wistar rats received one of the following: saline, AS, or mismatch (MM) oligonucleotide at 0.4 mg/kg iv at 12 and 24 h before LPS (5 mg/kg iv). The fourth group received saline only. Mean arterial pressure (MAP) and heart rate (HR) were continuously recorded before and 6 h after LPS or saline administration. Aorta, lung lavage, and lung tissue were collected for determination of iNOS protein expression and NOS activity. Small mesenteric arteries (≈250 μm) were isolated, denuded of endothelium, and maintained at a constant intraluminal pressure of 40 mmHg for study in vitro. LPS produced significant tachycardia that was not altered by AS or MM oligonucleotide. AS, but not MM oligonucleotide, reduced the accumulation of cGMP, the increase in conversion of L-[3H]arginine to L-[3H]citrulline, and iNOS protein expression in tissue from LPS-treated rats. Small mesenteric arterial contraction to NE was significantly impaired in vessels from LPS-treated rats and was restored by AS, but not MM, oligonucleotide. In a rat model of septic shock, AS oligonucleotide to iNOS mRNA inhibits NOS activity and iNOS protein expression and prevents the vascular hyporeactivity to NE, which may contribute to hypotension in shock.

KW - Antisense oligonucleotide

KW - Inducible nitric oxide synthase

KW - Mesenteric small arteries

KW - Septic shock

UR - http://www.scopus.com/inward/record.url?scp=33750891772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750891772&partnerID=8YFLogxK

M3 - Article

VL - 275

SP - H1078-83

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3 Pt 2

ER -